MiR-185 Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human glioma

BackgroundPerturbation of DNA methylation is frequent in cancers and has emerged as an important mechanism involved in tumorigenesis. To determine how DNA methylation is modified in the genome of primary glioma, we used Methyl-DNA immunoprecipitation (MeDIP) and Nimblegen CpG promoter microarrays to identify differentially DNA methylation sequences between primary glioma and normal brain tissue samples.MethodsMeDIP-chip technology was used to investigate the whole-genome differential methylation patterns in glioma and normal brain tissues. Subsequently, the promoter methylation status of eight candidate genes was validated in 40 glioma samples and 4 cell lines by Sequenom's MassARRAY system. Then, the epigenetically regulated expression of these genes and the potential mechanisms were examined by chromatin immunoprecipitation and quantitative real-time PCR.ResultsA total of 524 hypermethylated and 104 hypomethylated regions were identified in glioma. Among them, 216 hypermethylated and 60 hypomethylated regions were mapped to the promoters of known genes related to a variety of important cellular processes. Eight promoter-hypermethylated genes (ANKDD1A, GAD1, HIST1H3E, PCDHA8, PCDHA13, PHOX2B, SIX3, and SST) were confirmed in primary glioma and cell lines. Aberrant promoter methylation and changed histone modifications were associated with their reduced expression in glioma. In addition, we found loss of heterozygosity (LOH) at the miR-185 locus located in the 22q11.2 in glioma and induction of miR-185 over-expression reduced global DNA methylation and induced the expression of the promoter-hypermethylated genes in glioma cells by directly targeting the DNA methyltransferases 1.ConclusionThese comprehensive data may provide new insights into the epigenetic pathogenesis of human gliomas.

[1]  M. Ladanyi,et al.  The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. , 2003, Cancer research.

[2]  M. Berger,et al.  Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. , 2007, Neuro-oncology.

[3]  Ozy Sjahputera,et al.  Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. , 2007, Cancer research.

[4]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[5]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[6]  Z. Zeng,et al.  LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathway. , 2006, Molecular biology of the cell.

[7]  L. Hood,et al.  DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis , 2009, Oncogene.

[8]  Y. Tomizawa,et al.  Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors , 2003, Oncogene.

[9]  司履生.  Cancer epigenetics , 2006 .

[10]  M. Toyota,et al.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. , 2008, Cancer research.

[11]  K. Robertson,et al.  DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer. , 2009, Cancer research.

[12]  Michael Weller,et al.  TP53 promoter methylation in human gliomas , 2005, Acta Neuropathologica.

[13]  S. Akbarian,et al.  Thomas Vicary and the Anatomie of Mans Body , 2006, Medical History.

[14]  Y. Katayama,et al.  Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas. , 2006, Oncology reports.

[15]  L. Ricci-Vitiani,et al.  Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment , 2008, Oncogene.

[16]  O. Wiestler,et al.  Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas. , 2005, Neoplasia.

[17]  J. Herman,et al.  Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. , 2001, Human molecular genetics.

[18]  J. Issa,et al.  Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia , 2008, Leukemia.

[19]  Y. Katayama,et al.  Promoter Hypermethylation of Mismatch Repair Gene hMLH1 Predicts the Clinical Response of Malignant Astrocytomas to Nitrosourea , 2005, Clinical Cancer Research.

[20]  S. Cross,et al.  Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer , 2007, Clinical Cancer Research.

[21]  G. Reifenberger,et al.  Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss , 2008, International journal of cancer.

[22]  Claudia Petritsch,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .

[23]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[24]  Peter A. Jones,et al.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.

[25]  Esteban Ballestar,et al.  Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome. , 2008, BioTechniques.

[26]  H. Ishibashi,et al.  Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma , 1993, Hepatology.

[27]  W. Ahn,et al.  An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. , 2009, International journal of oncology.

[28]  L. Bian,et al.  Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells. , 2005, Chinese medical journal.

[29]  Peter A. Jones,et al.  The Role of DNA Methylation in Mammalian Epigenetics , 2001, Science.

[30]  Y. Yonekawa,et al.  Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene. , 2001, Carcinogenesis.

[31]  John K Field,et al.  Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Turck,et al.  Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis , 2009, Journal of Neural Transmission.

[33]  Li Wang,et al.  Promoter Hypermethylation-mediated Inactivation of LRRC4 in Gliomas , 2008, BMC Molecular Biology.

[34]  Albert Jeltsch,et al.  Beyond Watson and Crick: DNA Methylation and Molecular Enzymology of DNA Methyltransferases , 2002, Chembiochem : a European journal of chemical biology.

[35]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[36]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[37]  Tetsuo Ito,et al.  A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. , 2006, Gastroenterology.

[38]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[39]  G. Hannon,et al.  A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases , 2008, Nature Structural &Molecular Biology.

[40]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[41]  Pengyuan Yang,et al.  ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis , 2009, Molecular carcinogenesis.

[42]  A. Munnich,et al.  Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma. , 2007, European journal of cancer.

[43]  David A Jones,et al.  Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  T. Rauch,et al.  CpG island hypermethylation in human astrocytomas. , 2010, Cancer research.

[45]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[46]  O. Wiestler,et al.  Epigenetic Silencing of the Protocadherin Family Member PCDH-γ-All in Astrocytomas , 2005 .

[47]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[48]  K. Hoang-Xuan,et al.  Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas , 2004, Oncogene.

[49]  G. Maira,et al.  Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.

[50]  Y. Katayama,et al.  Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas , 2003, Brain pathology.

[51]  P. Laird.  Cancer epigenetics. , 2005, Human molecular genetics.

[52]  Tae-You Kim,et al.  Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. , 2006, Cancer research.

[53]  Carsten O. Daub,et al.  MiR-107 and MiR-185 Can Induce Cell Cycle Arrest in Human Non Small Cell Lung Cancer Cell Lines , 2009, PloS one.

[54]  Hung-Ming Wang,et al.  Methylation of RASSF1A, RASSF2A, and HIN-1 Is Associated with Poor Outcome after Radiotherapy, but not Surgery, in Oral Squamous Cell Carcinoma , 2009, Clinical Cancer Research.

[55]  D. Xie,et al.  DNA repair gene O6‐methylguanine‐DNA methyltransferase: Promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors , 2003, Molecular carcinogenesis.

[56]  Thomas D. Schmittgen,et al.  Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. , 2008, Cancer research.

[57]  Erwin G. Van Meir,et al.  Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. , 2004, The American journal of pathology.

[58]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[59]  小峰 千明.  Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas , 2004 .

[60]  Luca Regli,et al.  Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide , 2004, Clinical Cancer Research.

[61]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[62]  Yijun Qi,et al.  DNA methylation mediated by a microRNA pathway. , 2010, Molecular cell.

[63]  I. Lerer,et al.  Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy. , 2005, Human molecular genetics.

[64]  E. Schuuring,et al.  Discovery of DNA methylation markers in cervical cancer using relaxation ranking , 2008, BMC Medical Genomics.